Abstract
Here we review the mechanisms by which Thymosin β4 (Tβ4) regulates angiogenesis, its role in processes, such as wound healing and tumour progression and we discuss in more detail the role of Tβ4 in the cardiovascular system and significant recent findings implicating Tβ4 as a potential therapeutic agent for ischaemic heart disease.
Similar content being viewed by others
References
Goldstein AL, Slater FD, White A (1966) Preparation, assay, and partial purification of a thymic lymphocytopoietic factor (thymosin). Proc Natl Acad Sci USA 56:1010–1017
Huff T, Muller C, Otto A, Netzker R, Hannappel E (2001) β-thymosins, small acidic peptides with multiple functions. Int J Biochem Cell Biol 33:205–220
Sanders MC, Goldstein AL, Wang Y (1992) Thymosin {beta}4 (Fx Peptide) is a potent regulator of actin polymerization in living cells. PNAS 89:4678–4682
Stanka Stoeva SHWV (1997) A novel β-thymosin from the sea urchin: extending the phylogenetic distribution of β-thymosins from mammals to echinoderms. J Pept Sci 3:282–290
Low TL, Hu SK, Goldstein AL (1981) Complete amino acid sequence of bovine thymosin β4: a thymic hormone that induces terminal deoxynucleotidyl transferase activity in thymocyte populations. Proc Natl Acad Sci USA 78:1162–1166
Low TL, Goldstein AL (1982) Chemical characterization of thymosin beta 4. J Biol Chem 257:1000–1006
Goldstein AL, Hannappel E, Kleinman HK (2005) Thymosin β4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol Med 11:421–429
Lere B, Massimo L, Bruce RZ (1998) Thymosin β15 expression in tumor cell lines with varying metastatic potential. Clin Exp Metastasis 16:227–233
Bao L, Loda M, Janmey PA, Stewart R, nand-Apte B, Zetter BR (1996) Thymosin β 15: a novel regulator of tumor cell motility upregulated in metastatic prostate cancer. Nat Med 2:1322–1328
Sun HQ, Kwiatkowska K, Yin HL (1995) Actin monomer binding proteins. Curr Opin Cell Biol 7:102–110
Ghosh M, Song X, Mouneimne G, Sidani M, Lawrence DS, Condeelis JS (2004) Cofilin promotes actin polymerization and defines the direction of cell motility. Science 304:743–746
Lappalainen P, Drubin D (1997) Cofilin promotes rapid actin filament turnover in vivo. Nature 388:78–82
Faix J, Rottner K (2006) The making of filopodia. Curr Opin Cell Biol 18:18–25
Chen H, Bernstein B, Bamburg J (2000) Regulating actin-filament dynamics in vivo. Trends Biol Sci 25:19–23
Van Troys M, Dewitte D, Goethals M, Carlier MF, Vandekerckhove J, AMpe C (1996) The actin binding site of thymosin beta 4 mapped by mutational analysis. EMBO J 15:201–210
Malinda KM, Sidhu GS, Banaudha KK, Gaddipati JP, Maheshwari RK, Goldstein AL, Kleinman HK (1998) Thymosin {alpha}1 stimulates endothelial cell migration, angiogenesis, and wound healing. J Immunol 160:1001–1006
Mu H, Ohashi R, Yang H, Wang X, Li M, Lin P, Yao Q, Chen C (2006) Thymosin beta10 inhibits cell migration and capillary-like tube formation of human coronary artery endothelial cells. Cell Motil Cytoskeleton 63(4):222–230
Koutrafouri V, Leoniadis L, Avgoustakis K, Livianou E, Czarnecki J, Ithakissios D, Evangelatos G (2001) Effect of thymosin peptides on the chick chorioallantoic membrane angiogenesis model. Biochim Biophys Acta 1568:60–66
Koutrafouri V, Leondiadis L, Ferderigos N, Avgoustakis K, Livaniou E, Evangelatos GP, Ithakissios DS (2003) Synthesis and angiogenetic activity in the chick chorioallantoic membrane model of thymosin β15. Peptides 24:107–115
Lee SH, Son MJ, Oh SH, Rho SB, Park K, Kim YJ, Park MS, Lee JH (2005) Thymosin β10 inhibits angiogenesis and tumor growth by interfering with Ras function. Cancer Res 65:137–148
Philp D, Huff T, Gho YS, Hannappel E, Kleinman HK (2003) The actin binding site on thymosin β4 promotes angiogenesis. FASEB J 17:2103–2105
Gomez-Marquez J, del Amo F, Carpintero P, Anadon R (1996) High levels of mouse thymosin β4 mRNA in differentiating P19 embryonic cells and during development of cardiovascular tissues. Biochim Biophys Acta 1306:187–193
Carpintero P, Franco dA, Anadon R, Gomez-Marquez J (1996) Thymosin β10 mRNA expression during early postimplantation mouse development. FEBS Lett 394:103–106
Hall AK (1991) Differential expression of thymosin genes in human tumors and in the developing human kidney. Int J Cancer 48:672–677
Grant D, Kinsella J, Kibbey M, LaFlamme S, Burbelo P, Goldstein A, Leinman H (1995) Matrigel induces thymosin(β4 gene in differentiating endothelial cells. J Cell Sci 108:3685–3694
Malinda K, Goldstein A, Kleinman H (1997) Thymosin β4 stimulates directional migration of human umbilical vein endothelial cells. FASEB J 11:474–481
Grant DS, Rose W, Yaen C, Goldstein A, Martinez J, Kleinman H (1999) Thymosin β4 enhances endothelial cell differentiation and angiogenesis. Angiogenesis 3:125–135
Malinda K, Sidhu G, Mani H, Banaudha K, Mashewari R, Goldstein A, Kleinman H (1999) Thymosin β4 accelerates wound healing. J Invest Dermatol 113:364–368
Cha HJ, Jeong MJ, Kleinman HK (2003) Role of thymosin β4 in tumor metastasis and angiogenesis. J Natl Cancer Inst 95:1674–1680
Grillon C, Rieger K, Bakala J, Schott D, Morgat JL, Hannappel E, Voelter W, Lenfant M (1990) Involvement of thymosin β4 and endoproteinase Asp-N in the biosynthesis of the tetrapeptide AcSerAspLysPro a regulator of the hematopoietic system. FEBS Lett 274:30–34
Rieger KJ, Saez-Servent N, Papet MP, Wdzieczak-Bakala J, Morgat JL, Thierry J, Voelter W, Lenfant M (1993) Involvement of human plasma angiotensin I-converting enzyme in the degradation of the haemoregulatory peptide N-acetyl-seryl-aspartyl-lysyl-proline. Biochem J 296(Pt 2):373–378
Cavasin MA, Rhaleb NE, Yang XP, Carretero OA (2004) Prolyl oligopeptidase is involved in release of the antifibrotic peptide Ac-SDKP. Hypertension 43:1140–1145
Liu JM, Lawrence F, Kovacevic M, Bignon J, Papadimitriou E, Lallemand JY, Katsoris P, Potier P, Fromes Y, Wdzieczak-Bakala J (2003) The tetrapeptide AcSDKP, an inhibitor of primitive hematopoietic cell proliferation, induces angiogenesis in vitro and in vivo. Blood 101:3014–3020
Bonnet D, Lemoine FM, Frobert Y, Bonnet ML, Baillou C, Najman A, Guigon M (1996) Thymosin(β4, inhibitor for normal hematopoietic progenitor cells. Exp Hematol 24:776–782
Frohm M, Gunne H, Bergman AC, Agerberth B, Bergman T, Boman A, Liden S, Jornvall H, Boman HG (1996) Biochemical and antibacterial analysis of human wound and blister fluid. Eur J Biochem 237:86–92
Philp D, Badamchian M, Scheremeta B, Nguyen M, Goldstein A, Kleinman H (2003) Thymosin β4 and a synthetic peptide containing its actin-binding domain promote dermal wound repair in db/db diabetic mice and in aged mice. Wound Repair Regen 11:19–24
Philp D, Goldstein AL, Kleinman HK (2004) Thymosin [beta]4 promotes angiogenesis, wound healing, and hair follicle development. Mech Ageing Dev 125:113–115
Sosne G, Chan C, Thai K, Kennedy M, Szliter E, Hazlett L, Kleinman H (2001) Thymosin beta 4 promotes corneal wound healing and modulates inflammatory mediators in vivo. Exp Eye Res 72:605–608
Sosne G, Hafeez S, Greenberry AL, Kurpakus-Wheater M (2002) Thymosin beta4 promotes human conjunctival epithelial cell migration. Curr Eye Res 24:268–273
Sosne G, Siddiqi A, Kurpakus-Wheater M (2004) Thymosin-{beta}4 Inhibits Corneal Epithelial Cell Apoptosis after Ethanol Exposure In vitro. Invest Ophthalmol Vis Sci 45:1095–1100
Sosne G, Christopherson PL, Barrett RP, Fridman R (2005) Thymosin-{beta}4 modulates corneal matrix metalloproteinase levels and polymorphonuclear cell infiltration after alkali injury. Invest Ophthalmol Vis Sci 46:2388–2395
Sosne G, Qiu P, Christopherson PL, Wheater MK (2007) Thymosin beta 4 suppression of corneal NF[kappa]B: a potential anti-inflammatory pathway. Exp Eye Res 84:663–669
Clark E, Golub T, Lander E, Hynes R (2000) Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406:532–535
Ridley A (2000) Molecular switches in metastasis. Nature 406:466–467
Kobayashi T, Okada F, Fujii N, Tomita N, Ito S, Tazawa H, Ayoama T, Choi S, Shibita T, Fujita H, Hosokawa M (2002) Thymosin-β4 regulates motility and metastasis of malignant mouse fibrosarcoma cells. Am J Pathol 160:869–882
Diamond DL, Zhang Y, Gaiger A, Smithgall M, Vedvick TS, Carter D (2003) Use of proteinchip(TM) array surface enhanced laser desorption/ionization time-of-flight mass spectrometry (seldi-tof ms) to identify thymosin [beta]-4, a differentially secreted protein from lymphoblastoid cell lines. J Am Soc Mass Spectrom 14:760–765
Wang W-S, Chen P-M, Hsiao H-L, Ju S-Y, Su Y (2003) Overexpression of the thymosin b-4 gene is associated with malignant progression of SW480 colon cancer cells. Oncogene 22:3297–3306
Yamamoto T, Gotoh M, Kitajima M, Hirohashi S (1993) Thymosin [beta]-4 expression is correlated with metastatic capacity of colorectal carcinomas. Biochem Biophys Res Commun 193:706–710
Verghese-Nikolakaki S, Apostolikas N, Livaniou E, Ithakissios DS, Evangelatos GP (1996) Preliminary findings on the expression of thymosin beta-10 in human breast cancer. Br J Cancer 74:1441–1444
Santelli G, Califano D, Chiappetta G, Vento MT, Bartoli PC, Zullo F, Trapasso F, Viglietto G, Fusco A (1999) Thymosin beta-10 gene overexpression is a general event in human carcinogenesis. Am J Pathol 155:799–804
Viglietto G, Califano D, Bruni P, Baldassarre G, Vento MT, Belletti B, Fedele M, Santelli G, Boccia A, Manzo G, Santoro M, Fusco A (1999) Regulation of thymosin beta10 expression by TSH and other mitogenic signals in the thyroid gland and in cultured thyrocytes. Eur J Endocrinol 140:597–607
Lee S-H, Zhang W, Choi J-J, Cho Y-S, Lee S-H, Kim J-W, Hu L, Xu J, Liu J, Lee J-H (2001) Overexpression of the thymosin β-10 gene in human ovarian cancer cells disrupts F-actin stress fiber and leads to apoptosis. Oncogene 20:6700–6706
Kusinski M, Wdzieczak-Bakala J, Liu JM, Bignon J, Kuzdak K (2006) AcSDKP: a new potential marker of malignancy of the thyroid gland. Langenbecks Arch Surg 391:9–12
Smart N, Hill AA, Cross JC, Riley PR (2002) A differential screen for putative targets of the bHLH transcription factor Hand1 in cardiac morphogenesis. Mech Dev 119:S65–S71
Bock-Marquette I, Saxena A, White MD, Dimaio JM, Srivastava D (2004) Thymosin β4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature 432:466–472
Smart N, Risebro CA, Melville AAD, Moses K, Schwartz RJ, Chien KR, Riley PR (2007) Thymosin β4 induces adult epicardial progenitor mobilization and neovascularization. Nature 445:177–182
Dathe V, Brand-Saberi B (2004) Expression of thymosin beta4 during chick development. Anat Embryol (Berl) 208:27–32
Schultheiss TM, Xydas S, Lassar AB (1995) Induction of avian cardiac myogenesis by anterior endoderm. Development 121:4203–4214
Carmeliet P (2000) Mechanisms of angiogenesis and arteriogenesis. Nat Med 6:389–395
Risau W (1997) Mechanisms of angiogenesis. Nature 386:671–674
von Kodolitsch Y, Franzen O, Lund GK, Koschyk DH, Ito WD, Meinertz T (2004) Coronary artery anomalies Part I: recent insights from molecular embryology. Z Kardiol 93:929–937
Poelmann RE, Lie-Venema H, Gittenberger-de Groot AC (2002) The role of the epicardium and neural crest as extracardiac contributors to coronary vascular development. Tex Heart Inst J 29:255–261
Manasek FJ (1969) Embryonic development of the heart. II. Formation of the epicardium. J Embryol Exp Morphol 22:333–348
Viragh S, Challice CE (1981) The origin of the epicardium and the embryonic myocardial circulation in the mouse. Anat Rec 201:157–168
Munoz-Chapuli R, Gonzalez-Iriarte M, Carmona R, Atencia G, Macias D, Perez-Pomares JM (2002) Cellular precursors of the coronary arteries. Tex Heart Inst J 29:243–249
Wessels A, Perez-Pomares JM (2004) The epicardium and epicardially derived cells (EPDCs) as cardiac stem cells. Anat Rec A Discov Mol Cell Evol Biol 276:43–57
Ward NL, Dumont DJ (2002) The angiopoietins and Tie2/Tek: adding to the complexity of cardiovascular development. Semin Cell Dev Biol 13:19–27
Chen TH, Chang TC, Kang JO, Choudhary B, Makita T, Tran CM, Burch JBE, Eid H, Sucov HM (2002) Epicardial induction of fetal cardiomyocyte proliferation via a retinoic acid-inducible trophic factor. Dev Biol 250:198–207
van Tuyn J, Atsma DE, Winter EM, van der Velde-van Dijke I, Pijnappels DA, Bax NAM, Knaan-Shanzer S, Gittenberger-de Groot AC, Poelmann RE, van der Laarse A, van der Wall EE, Schalij MJ, de Vries AAF (2006) Epicardial cells of human adults can undergo an epithelial-to-mesenchymal transition and obtain characteristics of smooth muscle cells in vitro. Stem Cells 25:271–278, DOI:10.1634/stemcells.2006–0366
Lepilina A, Coon AN, Kikuchi K, Holdway JE, Roberts RW, Burns C, Poss KD (2006) A dynamic epicardial injury response supports progenitor cell activity during zebrafish heart regeneration. Cell 127:607–619
Lien CL, Schebesta M, Makino S, Weber GJ, Keating MT (2006) Gene expression analysis of zebrafish heart regeneration. PLoS Biol 4(8):e260
Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM, Leri A, Anversa P (2001) Bone marrow cells regenerate infarcted myocardium. Nature 410:701–705
Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Nakajima HO, Rubart M, Pasumarthi KB, Virag JI, Bartelmez SH, Poppa V, Bradford G, Dowell JD, Williams DA, Field LJ (2004) Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428:664–668
Gnecchi M, He H, Noiseux N, Liang OD, Zhang L, Morello F, Mu H, Melo LG, Pratt RE, Ingwall JS, Dzau VJ (2006) Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J 20:661–669
Isner JM, Asahara T (1999) Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J Clin Invest 103:1231–1236
Rafii S, Lyden D, Benezra R, Hattori K, Heissig B (2002) Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy? Nat Rev Cancer 2:826–835
Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, Magner M, Isner JM, Asahara T (1999) Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5:434–438
Kalka C, Isner JM (2002) [Cardiac and vascular gene therapy in cardiology. Current status and future prospects]. Internist (Berl) 43(Suppl 1):S66–S75
Reyes M, Dudek A, Jahagirdar B, Koodie L, Marker PH, Verfaillie CM (2002) Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 109:337–346
Wei J, Blum S, Unger M, Jarmy G, Lamparter M, Geishauser A, Vlastos GA, Chan G, Fischer KD, Rattat D, Debatin KM, Hatzopoulos AK, Beltinger C (2004) Embryonic endothelial progenitor cells armed with a suicide gene target hypoxic lung metastases after intravenous delivery. Cancer Cell 5:477–488
Vajkoczy P, Blum S, Lamparter M, Mailhammer R, Erber R, Engelhardt B, Vestweber D, Hatzopoulos AK (2003) Multistep nature of microvascular recruitment of ex vivo-expanded embryonic endothelial progenitor cells during tumor angiogenesis. J Exp Med 197:1755–1765
Kupatt C, Horstkotte J, Vlastos GA, Pfosser A, Lebherz C, Semisch M, Thalgott M, Buttner K, Browarzyk C, Mages J, Hoffmann R, Deten A, Lamparter M, Muller F, Beck H, Buning H, Boekstegers P, Hatzopoulos AK (2005) Embryonic endothelial progenitor cells expressing a broad range of proangiogenic and remodeling factors enhance vascularization and tissue recovery in acute and chronic ischemia. FASEB J 19:1576–1578
Huff T, Rosorius O, Otto AM, Muller CSG, Ballweber E, Hannappel E, Mannherz HG (2004) Nuclear localisation of the G-actin sequestering peptide thymosin β4. J Cell Sci 117:5333–5341
Golla R, Philp N, Chintipalli J, Hoffmann R, Collins L, Nachmias V (1997) Co-ordinate regulation of the cytoskeleton in 3T3 cells overexpressing thymosin-β4. Cell Motil Cytoskeleton 38:187–200
Moon HS, Even-Ram S, Kleinman HK, Cha HJ (2006) Zyxin is upregulated in the nucleus by thymosin beta4 in SiHa cells. Exp Cell Res 312:3425–3431
Sosne G, Xu L, Prach L, Mrock LK, Kleinman HK, Letterio JJ, Hazlett LD, Kurpakus-Wheater M (2004) Thymosin beta 4 stimulates laminin-5 production independent of TGF-beta. Exp Cell Res 293:175–183
Chang C, Werb Z (2001) The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol 11:S37–S43
Hannappel E, Leibold W (1985) Biosynthesis rates and content of thymosin β4 in cell lines. Arch Biochem Biophys 240:236–241
Huang WQ, Wang QR (2001) Bone marrow endothelial cells secrete thymosin β4 and AcSDKP. Exp Hematol 29:12–18
Huang HC, Hu CH, Tang MC, Wang WS, Chen PM, Su Y (2006) Thymosin β4 triggers an epithelial-mesenchymal transition in colorectal carcinoma by upregulating integrin-linked kinase. Oncogene 26(19):2781–2790
Acknowledgements
We thank all of the investigators who allowed us to reproduce figures and provided originals, as referenced. Our work is supported by the British Heart Foundation and the Medical Research Council.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Smart, N., Rossdeutsch, A. & Riley, P.R. Thymosin β4 and angiogenesis: modes of action and therapeutic potential. Angiogenesis 10, 229–241 (2007). https://doi.org/10.1007/s10456-007-9077-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10456-007-9077-x